ZIVO Bioscience Inc. (ZIVO)
18.10
-0.25 (-1.36%)
At close: Jan 14, 2025, 7:01 PM
undefined% (undefined)
| Bid | n/a |
| Market Cap | 64.19M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.83 |
| PE Ratio (ttm) | -3.75 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 227 |
| Avg. Volume (20D) | 1,493 |
| Open | 18.00 |
| Previous Close | 18.35 |
| Day's Range | 18.00 - 18.10 |
| 52-Week Range | 3.13 - 22.15 |
| Beta | undefined |
About ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniq...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 15, 2003
Employees 8
Stock Exchange NASDAQ
Ticker Symbol ZIVO
Website https://www.zivobioscience.com
Analyst Forecast
According to 1 analyst ratings, the average rating for ZIVO stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
ZIVO Bioscience Inc. is scheduled to release its earnings on Mar 14, 2025,
during market hours.
Analysts project revenue of $150.00K, reflecting a 1.17K% YoY growth and earnings per share of -0.36, making a -62.50% decrease YoY.
Analysts project revenue of $150.00K, reflecting a 1.17K% YoY growth and earnings per share of -0.36, making a -62.50% decrease YoY.
